Patents by Inventor Scott Wolkenberg

Scott Wolkenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Potassium Channel Inhibitors
    Publication number: 20090233897
    Abstract: The present invention relates to compounds having the structure useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
    Type: Application
    Filed: October 17, 2006
    Publication date: September 17, 2009
    Inventors: B. Wesley Trotter, Kausik K. Nanda, Scott Wolkenberg, M. Brad Nolt, Peter Manley, Nathan R. Kett, Mark T. Bilodeau
  • Potassium Channel Inhibitors
    Publication number: 20090042944
    Abstract: The present invention relates to compounds having the structure useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
    Type: Application
    Filed: October 17, 2006
    Publication date: February 12, 2009
    Inventors: Scott Wolkenberg, Mark T. Bilodeau, M. Brad Nolt
  • Azetidine Glycine Transporter Inhibitors
    Publication number: 20080021010
    Abstract: The present invention is directed to azetidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
    Type: Application
    Filed: April 25, 2005
    Publication date: January 24, 2008
    Inventors: Craig Lindsley, David Hallett, Scott Wolkenberg
  • Heteroaryl Piperidine Glycine Transporter Inhibitors
    Publication number: 20070254880
    Abstract: The present invention is directed to pyridyl, pyridazinyl, pyrimidinyl and pyrazinyl piperidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
    Type: Application
    Filed: March 23, 2005
    Publication date: November 1, 2007
    Inventors: Wesley Blackaby, Mark Duggan, David Hallett, George Hartman, Andrew Jennings, William Leister, Richard Lewis, Craig Lindsley, Elizabeth Naylor, Leslie Street, Yi Wang, David Wisnoski, Scott Wolkenberg, Zhijian Zhao
  • Morpholinyl Piperidine Glycine Transporter Inhibitors
    Publication number: 20070249606
    Abstract: The present invention is directed to morpholinyl piperidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
    Type: Application
    Filed: April 29, 2005
    Publication date: October 25, 2007
    Inventors: Craig Lindsley, Scott Wolkenberg, Zhijian Zhao